METHOD OF IDENTIFICATION AGENT BASED ON HIGH THROUGHPUT SCREENING Russian patent published in 2013 - IPC C12N15/10 C12Q1/68 

Abstract RU 2486247 C2

FIELD: biotechnology.

SUBSTANCE: method comprises the following stages: preparing cells in the first set comprising at least 96 receivers, adding an agent at least to one receiver; incubating the agent with the cells, lysing the cells by adding a buffer which is hypotonic or comprises detergent, and contains an inhibitor of DNAase; removal of RNA from the cell lysate with ribonuclease; centrifugation of the first set of receivers at low speed; transfer of a supernatant containing DNA fragments to the second set of receivers; adding a detectable compound capable of intercalation with DNA fragments in a buffer for detection containing DNAase inhibitor to at least one receiver; measuring the amount of intercalated detectable compound; and comparing the amount of intercalated detectable compound to the control for determining the difference that enables to identify the said agent as a modifying agent if the difference exceeds a predetermined limit.

EFFECT: invention enables to detect agents that affect the formation of DNA fragments in cells using high performance screening applications.

10 cl, 14 dwg, 2 tbl, 11 ex

Similar patents RU2486247C2

Title Year Author Number
COMPOSITION AND METHOD OF TUMOUR CURING 2007
  • Ogast Pol
  • Khuan Vaan Tszen
  • Natesan Shridaran
  • Liberman Sojan
RU2500815C2
SYNTHETIC LETHALITY AND TREATMENT OF CANCER 2013
  • Bertom Lyuk G.
  • Perinpanayagam Konganig Maneka Ann
  • Yap Chuiee
  • Boshamp Ervan
RU2676697C2
AGENT WITH ANTIAPOPTOTIC ACTIVITY 2018
  • Kampe-Nemm Elena Arturovna
  • Kolobov Aleksandr Aleksandrovich
  • Rogovskaya Nadezhda Yurevna
  • Babakov Vladimir Nikolaevich
RU2685428C1
HUMANISED MONOCLONAL ANTIBODY SPECIFIC FOR LEGUMAIN 2013
  • Dukhovlinov Il'Ja Vladimirovich
  • Orlov Anton Iosifovich
RU2574203C2
ANTAGONIST-LIGAND RAR-γ OR AGONIST-LIGAND RAR-α AS INHIBITOR OF APOPTOSIS 1996
  • Feshush Laslo
  • Sondi Zhuzha
  • Rajkhert Uve
RU2191008C2
METHOD OF ISOLATION OF HIGH-MOLECULAR PROTEIN ACTIVATION COMPLEX OF HUMAN CASPASE-2 2016
  • Kopeina Gelina Sergeevna
  • Zamaraev Aleksej Vladimirovich
  • Lavrik Inna Nikolaevna
  • Zhivotovskij Boris Davidovich
RU2671510C1
COMPOSITION AND METHOD FOR TREATMENT OF EYE DISEASE ASSICIATED WITH NUCLEIC ACIDS 2012
  • Dzhain Sandip
RU2642609C2
HYBRIDOMA DESIGNATES AS 199M AND MONOCLONAL ANTIBODY SECRETED BY THIS HYBRIDOMA 1997
  • Gehllatin Uil'Jam M.
  • Vehn Der Viren Monika
RU2183671C2
AGENT STIMULATING APOPTOSIS OF HUMAN LEUKAEMIA CELLS 2007
  • Fedorov Sergej Nikolaevich
  • Shubina Larisa Kimovna
  • Kapustina Irina Ivanovna
  • Avilov Sergej Anatol'Evich
  • Stonik Valentin Aronovich
  • Shastina Valerija Vladimirovna
  • Kvak Jang Jong
  • Park Dzhu In
  • Dzhin Dzhun O
  • Kvon Jang Khii
RU2360692C1
COMBINATION OF ANTIBODY HAVING SELECTIVITY IN RELATES TO APOPTOSIS INDUCING LIGAND RECEPTOR ASSOCIATED WITH TUMOR NECROSIS FACTOR AND OTHER THERAPEUTIC AGENTS 2002
  • Chzhou Tun
  • Itikava Kimikhisa
  • Kimberli Robert P.
  • Kupman Uil'Jam Dzh.
  • Osumi Dzhun
  • Lobuglio Al'Bert F.
  • Bukhsbaum Donal'D Dzh.
RU2313368C2

RU 2 486 247 C2

Authors

Garajantes Tina

Li Chzhuin'

Jan' Junpin

Ju Dzhastin Ehntoni

Zilberstejn Ehsher

Dates

2013-06-27Published

2007-06-20Filed